vs

Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and BLACKBERRY Ltd (BB). Click either name above to swap in a different company.

Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $141.8M, roughly 1.4× BLACKBERRY Ltd). BLACKBERRY Ltd runs the higher net margin — 9.7% vs -14.6%, a 24.2% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs -0.8%). BLACKBERRY Ltd produced more free cash flow last quarter ($17.4M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 17.8%).

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.

BlackBerry Limited, formerly Research In Motion (RIM), is a Canadian software company specializing in secure communications and the Internet of Things (IoT). Founded in 1984, it developed the BlackBerry brand of two-way pagers, smartphones, and tablets. The company later transitioned to providing software and services and holds critical software application patents.

AXSM vs BB — Head-to-Head

Bigger by revenue
AXSM
AXSM
1.4× larger
AXSM
$196.0M
$141.8M
BB
Growing faster (revenue YoY)
AXSM
AXSM
+65.9% gap
AXSM
65.0%
-0.8%
BB
Higher net margin
BB
BB
24.2% more per $
BB
9.7%
-14.6%
AXSM
More free cash flow
BB
BB
$36.1M more FCF
BB
$17.4M
$-18.7M
AXSM
Faster 2-yr revenue CAGR
AXSM
AXSM
Annualised
AXSM
61.7%
17.8%
BB

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
AXSM
AXSM
BB
BB
Revenue
$196.0M
$141.8M
Net Profit
$-28.6M
$13.7M
Gross Margin
77.5%
Operating Margin
-13.8%
8.4%
Net Margin
-14.6%
9.7%
Revenue YoY
65.0%
-0.8%
Net Profit YoY
61.9%
224.5%
EPS (diluted)
$-0.55
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXSM
AXSM
BB
BB
Q4 25
$196.0M
$141.8M
Q3 25
$171.0M
$129.6M
Q2 25
$150.0M
$121.7M
Q1 25
$121.5M
$141.7M
Q4 24
$118.8M
$143.6M
Q3 24
$104.8M
$126.2M
Q2 24
$87.2M
$123.4M
Q1 24
$75.0M
$102.1M
Net Profit
AXSM
AXSM
BB
BB
Q4 25
$-28.6M
$13.7M
Q3 25
$-47.2M
$13.3M
Q2 25
$-48.0M
$1.9M
Q1 25
$-59.4M
$-7.4M
Q4 24
$-74.9M
$-10.5M
Q3 24
$-64.6M
$-19.7M
Q2 24
$-79.3M
$-41.4M
Q1 24
$-68.4M
$-56.2M
Gross Margin
AXSM
AXSM
BB
BB
Q4 25
77.5%
Q3 25
74.5%
Q2 25
74.2%
Q1 25
73.5%
Q4 24
78.1%
Q3 24
70.2%
Q2 24
72.9%
Q1 24
Operating Margin
AXSM
AXSM
BB
BB
Q4 25
-13.8%
8.4%
Q3 25
-27.0%
8.9%
Q2 25
-24.5%
1.6%
Q1 25
-46.9%
-5.6%
Q4 24
-61.1%
13.6%
Q3 24
-59.8%
1.7%
Q2 24
-89.5%
-10.5%
Q1 24
-89.7%
50.0%
Net Margin
AXSM
AXSM
BB
BB
Q4 25
-14.6%
9.7%
Q3 25
-27.6%
10.3%
Q2 25
-32.0%
1.6%
Q1 25
-48.9%
-5.2%
Q4 24
-63.1%
-7.3%
Q3 24
-61.7%
-15.6%
Q2 24
-91.0%
-33.5%
Q1 24
-91.1%
-55.0%
EPS (diluted)
AXSM
AXSM
BB
BB
Q4 25
$-0.55
$0.02
Q3 25
$-0.94
$0.02
Q2 25
$-0.97
$0.00
Q1 25
$-1.22
$-0.01
Q4 24
$-1.54
$-0.02
Q3 24
$-1.34
$-0.03
Q2 24
$-1.67
$-0.07
Q1 24
$-1.44
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXSM
AXSM
BB
BB
Cash + ST InvestmentsLiquidity on hand
$322.9M
$304.2M
Total DebtLower is stronger
$196.2M
Stockholders' EquityBook value
$88.3M
$741.1M
Total Assets
$689.8M
$1.2B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXSM
AXSM
BB
BB
Q4 25
$322.9M
$304.2M
Q3 25
$325.3M
$290.5M
Q2 25
$303.0M
$306.6M
Q1 25
$300.9M
$337.8M
Q4 24
$315.4M
$220.0M
Q3 24
$327.3M
$211.0M
Q2 24
$315.7M
$229.0M
Q1 24
$331.4M
$237.1M
Total Debt
AXSM
AXSM
BB
BB
Q4 25
$196.2M
Q3 25
$195.9M
Q2 25
$195.6M
Q1 25
$195.3M
Q4 24
Q3 24
Q2 24
Q1 24
$194.1M
Stockholders' Equity
AXSM
AXSM
BB
BB
Q4 25
$88.3M
$741.1M
Q3 25
$73.7M
$725.1M
Q2 25
$73.1M
$725.1M
Q1 25
$53.2M
$719.9M
Q4 24
$57.0M
$725.2M
Q3 24
$92.9M
$732.1M
Q2 24
$102.9M
$742.6M
Q1 24
$144.0M
$775.1M
Total Assets
AXSM
AXSM
BB
BB
Q4 25
$689.8M
$1.2B
Q3 25
$669.3M
$1.2B
Q2 25
$639.8M
$1.2B
Q1 25
$596.7M
$1.3B
Q4 24
$568.5M
$1.3B
Q3 24
$561.5M
$1.3B
Q2 24
$548.2M
$1.3B
Q1 24
$545.7M
$1.4B
Debt / Equity
AXSM
AXSM
BB
BB
Q4 25
0.26×
Q3 25
0.27×
Q2 25
0.27×
Q1 25
0.27×
Q4 24
Q3 24
Q2 24
Q1 24
0.25×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXSM
AXSM
BB
BB
Operating Cash FlowLast quarter
$-18.7M
$18.3M
Free Cash FlowOCF − Capex
$-18.7M
$17.4M
FCF MarginFCF / Revenue
-9.6%
12.3%
Capex IntensityCapex / Revenue
0.0%
0.6%
Cash ConversionOCF / Net Profit
1.34×
TTM Free Cash FlowTrailing 4 quarters
$-93.9M
$42.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXSM
AXSM
BB
BB
Q4 25
$-18.7M
$18.3M
Q3 25
$1.0M
$3.9M
Q2 25
$-32.4M
$-18.0M
Q1 25
$-43.4M
$41.6M
Q4 24
$-26.2M
$6.0M
Q3 24
$-18.6M
$-16.0M
Q2 24
$-30.1M
$-15.1M
Q1 24
$-53.5M
$-15.5M
Free Cash Flow
AXSM
AXSM
BB
BB
Q4 25
$-18.7M
$17.4M
Q3 25
$988.0K
$3.1M
Q2 25
$-32.4M
$-18.9M
Q1 25
$-43.7M
$41.2M
Q4 24
$-26.2M
$5.2M
Q3 24
$-18.7M
$-16.5M
Q2 24
$-30.2M
$-16.5M
Q1 24
$-53.6M
$-17.6M
FCF Margin
AXSM
AXSM
BB
BB
Q4 25
-9.6%
12.3%
Q3 25
0.6%
2.4%
Q2 25
-21.6%
-15.5%
Q1 25
-36.0%
29.1%
Q4 24
-22.1%
3.6%
Q3 24
-17.9%
-13.1%
Q2 24
-34.6%
-13.4%
Q1 24
-71.4%
-17.2%
Capex Intensity
AXSM
AXSM
BB
BB
Q4 25
0.0%
0.6%
Q3 25
0.0%
0.6%
Q2 25
0.0%
0.7%
Q1 25
0.3%
0.3%
Q4 24
0.0%
0.6%
Q3 24
0.1%
0.4%
Q2 24
0.1%
1.1%
Q1 24
0.1%
2.1%
Cash Conversion
AXSM
AXSM
BB
BB
Q4 25
1.34×
Q3 25
0.29×
Q2 25
-9.47×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXSM
AXSM

Segment breakdown not available.

BB
BB

QNX$68.7M48%
Secure Communication$67.0M47%
Licensing$6.1M4%

Related Comparisons